These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38527714)

  • 1. Circulating soluble CD30 is associated with renal tertiary lymphoid structures and the progression of IgA nephropathy.
    Luo R; Qian D; Yang D; Cheng Y; Li J; Liu L; Li Y; Lei Q; Chang X; Liu Y; Xu G; Ge S
    Clin Chim Acta; 2024 Apr; 557():117888. PubMed ID: 38527714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and prognostic significance of C1q deposition in IgAN patients-a retrospective study.
    Tian S; Yang X; Luo J; Guo H
    Int Immunopharmacol; 2020 Nov; 88():106896. PubMed ID: 33182045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microangiopathic Lesions in IgA Nephropathy: A Cohort Study.
    Cai Q; Shi S; Wang S; Ren Y; Hou W; Liu L; Lv J; Haas M; Zhang H
    Am J Kidney Dis; 2019 Nov; 74(5):629-639. PubMed ID: 31103332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High Neutrophil-To-Lymphocyte Ratio Is an Independent Risk Factor for End Stage Renal Diseases in IgA Nephropathy.
    Wang S; Dong L; Pei G; Jiang Z; Qin A; Tan J; Tang Y; Qin W
    Front Immunol; 2021; 12():700224. PubMed ID: 34456912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The predictive value of free thyroxine combined with tubular atrophy/interstitial fibrosis for poor prognosis in patients with IgA nephropathy.
    Yang B; Zhou W; Cui L; Tian L; Ni Y; Yang M; Yang Y
    Front Endocrinol (Lausanne); 2024; 15():1372824. PubMed ID: 38808109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum complement factor B is associated with disease activity and progression of idiopathic membranous nephropathy concomitant with IgA nephropathy.
    Ji FP; Wen L; Zhang YP; Liu EP; Wen JG
    Int Urol Nephrol; 2022 Jun; 54(6):1287-1294. PubMed ID: 34585312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between urinary C4d levels and disease progression in IgA nephropathy.
    Dong Y; Wang Z; Guo W; Zhu L; Zhou X; Shi S; Liu L; Lv J; Zhang H
    Nephrol Dial Transplant; 2024 Jul; 39(8):1279-1287. PubMed ID: 38178632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glomerular C4 deposition and glomerulosclerosis predict worse renal outcomes in Chinese patients with IgA nephropathy.
    Yang Y; Tang X; Yang Y; Li X; Li L; Huang K; Li Y; Li J; Fu P
    Ren Fail; 2020 Nov; 42(1):629-637. PubMed ID: 32660366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic value of the systemic immune inflammation index in patients with IgA nephropathy.
    Zhai Y; Sun S; Zhang W; Tian H
    Ren Fail; 2024 Dec; 46(2):2381613. PubMed ID: 39039867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High serum and urine neutrophil gelatinase-associated lipocalin levels are independent predictors of renal progression in patients with immunoglobulin A nephropathy.
    Rhee H; Shin N; Shin MJ; Yang BY; Kim IY; Song SH; Lee DW; Lee SB; Kwak IS; Seong EY
    Korean J Intern Med; 2015 May; 30(3):354-61. PubMed ID: 25995666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes of IgA nephropathy patients with different proportions of crescents.
    Zhang W; Zhou Q; Hong L; Chen W; Yang S; Yang Q; Chen W; Yu X
    Medicine (Baltimore); 2017 Mar; 96(11):e6190. PubMed ID: 28296731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. To evaluate the utility of Oxford classification in predicting renal outcome in IgA nephropathy patients.
    Saleem N; Nasir H; Anwar F; Aziz M; Khurshid K; Bashir S; Khan A
    Int Urol Nephrol; 2024 Jan; 56(1):345-353. PubMed ID: 37378850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum immunoglobulin G provides early risk prediction in immunoglobulin A nephropathy.
    Liu D; You J; Liu Y; Tang X; Tan X; Xia M; Wu L; Chen G; He L; Zhu X; Liu H
    Int Immunopharmacol; 2019 Jan; 66():13-18. PubMed ID: 30415190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positive renal familial history in IgA nephropathy is associated with worse renal outcomes: a single-center longitudinal study.
    Sato Y; Tsukaguchi H; Higasa K; Kawata N; Inui K; Linh TNT; Quynh TTH; Yoshihiko I; Koiwa F; Yoshimura A
    BMC Nephrol; 2021 Jun; 22(1):230. PubMed ID: 34147067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Association of Low Hemoglobin Levels with IgA Nephropathy Progression: A Two-Center Cohort Study of 1,828 Cases.
    Zhu B; Liu WH; Yu DR; Lin Y; Li Q; Tong ML; Li YY; Yang RC; Du YY; Tang XL; Jiang F; Fei D; Wei XY; Zhang FF; Yin JZ; Wang WR; Li XF; Sun Y; Zhong YZ; Zhang MJ; Cheng XX; Zhu CF; Chen HY
    Am J Nephrol; 2020; 51(8):624-634. PubMed ID: 32694247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary Matrix Metalloproteinase 7 and Prediction of IgA Nephropathy Progression.
    Yang X; Ou J; Zhang H; Xu X; Zhu L; Li Q; Li J; Xie D; Sun J; Zha Y; Li Y; Tian J; Liu Y; Hou FF
    Am J Kidney Dis; 2020 Mar; 75(3):384-393. PubMed ID: 31606236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A validation study of crescents in predicting ESRD in patients with IgA nephropathy.
    Zhang X; Shi S; Ouyang Y; Yang M; Shi M; Pan X; Lv J; Wang Z; Ren H; Shen P; Wang W; Zhang H; Xie J; Chen N
    J Transl Med; 2018 May; 16(1):115. PubMed ID: 29724226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal Interstitial Inflammation Predicts Nephropathy Progression in IgA Nephropathy: A Two-Center Cohort Study.
    Zhu B; Liu WH; Lin Y; Li Q; Yu DR; Jiang F; Tang XL; Du YY; Yin JZ; Li XF; Zhong YZ; Wang WR; Sun Y; Zhang MJ; Gao YC; Yuan CY; Zhu CF; Cheng XX
    Am J Nephrol; 2022; 53(6):455-469. PubMed ID: 35576899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of fibrinoid necrosis on the clinical features and outcomes of primary IgA nephropathy.
    Chen H; Liu Y; Wei L; Wang H; Zheng Z; Yan T; Jia J; Li D
    BMC Nephrol; 2023 Dec; 24(1):366. PubMed ID: 38082385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is it possible to predict the evolution of IgAN? Validation of the IgA nephropathy progression calculator and its relationship with MEST-C score in our population.
    Martín-Penagos L; Benito A; Oviedo MV; López Del Moral Cuesta C; Martín López J; Gómez Román J; López-Mejías R; Fernandez-Fresnedo G; Ruíz San Millán JC; Rodrigo Calabia E
    Nefrologia (Engl Ed); 2019; 39(5):523-530. PubMed ID: 30902505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.